<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34103710</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-0048</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature reviews. Neuroscience</Title><ISOAbbreviation>Nat Rev Neurosci</ISOAbbreviation></Journal><ArticleTitle>TDP43 aggregates: the 'Schr&#xf6;dinger's cat' in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>514</StartPage><MedlinePgn>514</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41583-021-00477-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lanznaster</LastName><ForeName>D&#xe9;bora</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5911-3120</Identifier><AffiliationInfo><Affiliation>UMR1253 iBrain, University of Tours, Tours, France. debora.lanznaster@univ-tours.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hergesheimer</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UMR1253 iBrain, University of Tours, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vourc'h</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UMR1253 iBrain, University of Tours, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corcia</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UMR1253 iBrain, University of Tours, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasco</LastName><ForeName>H&#xe9;l&#xe8;ne</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6107-0035</Identifier><AffiliationInfo><Affiliation>UMR1253 iBrain, University of Tours, Tours, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Neurosci</MedlineTA><NlmUniqueID>100962781</NlmUniqueID><ISSNLinking>1471-003X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nat Rev Neurosci. 2021 Apr;22(4):197-208</RefSource><PMID Version="1">33654312</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurosci. 2021 Aug;22(8):515</RefSource><PMID Version="1">34103711</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34103710</ArticleId><ArticleId IdType="doi">10.1038/s41583-021-00477-1</ArticleId><ArticleId IdType="pii">10.1038/s41583-021-00477-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tziortzouda, P., Van Den Bosch, L. &amp; Hirth, F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197&#x2013;208 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-021-00431-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg, E., Turner, M. R., Ansorge, O. &amp; Talbot, K. Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology. Neurology 95, 595&#x2013;596 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010587</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon, G. S. et al. Pathological modification of TDP-43 in amyotrophic lateral sclerosis with SOD1 mutations. Mol. Neurobiol. 56, 2007&#x2013;2021 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1218-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi, H. et al. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 68, 37&#x2013;47 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181919cb5</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto, Y. et al. An autopsy case of SOD1-related ALS with TDP-43 positive inclusions. Neurology 77, 1993&#x2013;1995 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31823a0cfc</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer, R. C. et al. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 142, 1176&#x2013;1194 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId></ArticleIdList></Reference><Reference><Citation>Somalinga, B. R., Day, C. E., Wei, S., Roth, M. G. &amp; Thomas, P. J. TDP-43 identified from a genome wide RNAi screen for SOD1 regulators. PLoS One 7, e35818 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035818</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou, M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459&#x2013;468 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening, K., Keller, B. A., Leystra-Lantz, C. &amp; Strong, M. J. RNA and protein interactors with TDP-43 in human spinal-cord lysates in amyotrophic lateral sclerosis. J. Proteome Res. 17, 1712&#x2013;1729 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00126</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi, S., Tsuchiya, Y., Araki, T., Wada, K. &amp; Kabuta, T. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase. Neurochem. Int. 57, 906&#x2013;913 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2010.09.010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>